お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は前立腺がん検診市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは前立腺がん検診の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の前立腺がん検診市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは前立腺がん検診のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に前立腺がん検診市場を分類しています。本研究に含まれる主な企業は：Abbott Laboratories、Almac、Bayer、Beckman Coulter、BioméRieux、Genomic Health、Mayo Clinic、Mdxhealth、Roche Diagnostics、Rosetta Genomics、Thermo Fisher Scientific、Hologic、Myriad Genetics

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Physical Exam
    Laboratory Tests
    Imaging Tests
    Gleason Score
    TNM Score
    Genetic Tests
    Digital Rectal Exam
    Biopsy

用途別の市場セグメント：
    Hospitals
    Clinics
    Research Labs
    Cancer Institutes
    Diagnostic Centers
    Others

本レポートの詳細内容
世界の前立腺がん検診市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、前立腺がん検診タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の前立腺がん検診収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の前立腺がん検診市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、前立腺がん検診市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

前立腺がん検診のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：前立腺がん検診のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：前立腺がん検診の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章前立腺がん検診企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：前立腺がん検診の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：前立腺がん検診の主要企業の概要を提供し、製品の説明と仕様、前立腺がん検診の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.

Market Analysis and Insights: Global Prostate Cancer Screening Market
The global Prostate Cancer Screening market is projected to grow from US$ 14570 million in 2024 to US$ 22660 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.6% during the forecast period.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
Report Covers:
This report presents an overview of global market for Prostate Cancer Screening market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Prostate Cancer Screening, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Cancer Screening, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate Cancer Screening revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Cancer Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate Cancer Screening revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Almac, Bayer, Beckman Coulter, BioméRieux, Genomic Health, Mayo Clinic, Mdxhealth and Roche Diagnostics, etc.

Market Segmentation
By Company
    Abbott Laboratories
    Almac
    Bayer
    Beckman Coulter
    BioméRieux
    Genomic Health
    Mayo Clinic
    Mdxhealth
    Roche Diagnostics
    Rosetta Genomics
    Thermo Fisher Scientific
    Hologic
    Myriad Genetics

Segment by Type
    Physical Exam
    Laboratory Tests
    Imaging Tests
    Gleason Score
    TNM Score
    Genetic Tests
    Digital Rectal Exam
    Biopsy

Segment by Application
    Hospitals
    Clinics
    Research Labs
    Cancer Institutes
    Diagnostic Centers
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate Cancer Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Screening companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Screening revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Prostate Cancer Screening Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Physical Exam
    Table 3. Key Players of Laboratory Tests
    Table 4. Key Players of Imaging Tests
    Table 5. Key Players of Gleason Score
    Table 6. Key Players of TNM Score
    Table 7. Key Players of Genetic Tests
    Table 8. Key Players of Digital Rectal Exam
    Table 9. Key Players of Biopsy
    Table 10. Global Prostate Cancer Screening Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 11. Global Prostate Cancer Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 12. Global Prostate Cancer Screening Market Size by Region (2019-2024) & (US$ Million)
    Table 13. Global Prostate Cancer Screening Market Share by Region (2019-2024)
    Table 14. Global Prostate Cancer Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 15. Global Prostate Cancer Screening Market Share by Region (2025-2030)
    Table 16. Prostate Cancer Screening Market Trends
    Table 17. Prostate Cancer Screening Market Drivers
    Table 18. Prostate Cancer Screening Market Challenges
    Table 19. Prostate Cancer Screening Market Restraints
    Table 20. Global Prostate Cancer Screening Revenue by Players (2019-2024) & (US$ Million)
    Table 21. Global Prostate Cancer Screening Revenue Share by Players (2019-2024)
    Table 22. Global Top Prostate Cancer Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Screening as of 2023)
    Table 23. Global Prostate Cancer Screening Industry Ranking 2022 VS 2023 VS 2024
    Table 24. Global 5 Largest Players Market Share by Prostate Cancer Screening Revenue (CR5 and HHI) & (2019-2024)
    Table 25. Global Key Players of Prostate Cancer Screening, Headquarters and Area Served
    Table 26. Global Key Players of Prostate Cancer Screening, Product and Application
    Table 27. Global Key Players of Prostate Cancer Screening, Product and Application
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Prostate Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 30. Global Prostate Cancer Screening Revenue Market Share by Type (2019-2024)
    Table 31. Global Prostate Cancer Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 32. Global Prostate Cancer Screening Revenue Market Share by Type (2025-2030)
    Table 33. Global Prostate Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 34. Global Prostate Cancer Screening Revenue Share by Application (2019-2024)
    Table 35. Global Prostate Cancer Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 36. Global Prostate Cancer Screening Revenue Share by Application (2025-2030)
    Table 37. North America Prostate Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 38. North America Prostate Cancer Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 39. North America Prostate Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 40. North America Prostate Cancer Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 41. North America Prostate Cancer Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. North America Prostate Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 43. North America Prostate Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Europe Prostate Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 45. Europe Prostate Cancer Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 46. Europe Prostate Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 47. Europe Prostate Cancer Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 48. Europe Prostate Cancer Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Europe Prostate Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Europe Prostate Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 51. China Prostate Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 52. China Prostate Cancer Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 53. China Prostate Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 54. China Prostate Cancer Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Prostate Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 56. Asia Prostate Cancer Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 57. Asia Prostate Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 58. Asia Prostate Cancer Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 59. Asia Prostate Cancer Screening Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 60. Asia Prostate Cancer Screening Market Size by Region (2019-2024) & (US$ Million)
    Table 61. Asia Prostate Cancer Screening Market Size by Region (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Prostate Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Prostate Cancer Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Prostate Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Prostate Cancer Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Prostate Cancer Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 67. Middle East, Africa, and Latin America Prostate Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 68. Middle East, Africa, and Latin America Prostate Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 69. Abbott Laboratories Company Details
    Table 70. Abbott Laboratories Business Overview
    Table 71. Abbott Laboratories Prostate Cancer Screening Product
    Table 72. Abbott Laboratories Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 73. Abbott Laboratories Recent Developments
    Table 74. Almac Company Details
    Table 75. Almac Business Overview
    Table 76. Almac Prostate Cancer Screening Product
    Table 77. Almac Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 78. Almac Recent Developments
    Table 79. Bayer Company Details
    Table 80. Bayer Business Overview
    Table 81. Bayer Prostate Cancer Screening Product
    Table 82. Bayer Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 83. Bayer Recent Developments
    Table 84. Beckman Coulter Company Details
    Table 85. Beckman Coulter Business Overview
    Table 86. Beckman Coulter Prostate Cancer Screening Product
    Table 87. Beckman Coulter Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 88. Beckman Coulter Recent Developments
    Table 89. BioméRieux Company Details
    Table 90. BioméRieux Business Overview
    Table 91. BioméRieux Prostate Cancer Screening Product
    Table 92. BioméRieux Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 93. BioméRieux Recent Developments
    Table 94. Genomic Health Company Details
    Table 95. Genomic Health Business Overview
    Table 96. Genomic Health Prostate Cancer Screening Product
    Table 97. Genomic Health Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 98. Genomic Health Recent Developments
    Table 99. Mayo Clinic Company Details
    Table 100. Mayo Clinic Business Overview
    Table 101. Mayo Clinic Prostate Cancer Screening Product
    Table 102. Mayo Clinic Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 103. Mayo Clinic Recent Developments
    Table 104. Mdxhealth Company Details
    Table 105. Mdxhealth Business Overview
    Table 106. Mdxhealth Prostate Cancer Screening Product
    Table 107. Mdxhealth Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 108. Mdxhealth Recent Developments
    Table 109. Roche Diagnostics Company Details
    Table 110. Roche Diagnostics Business Overview
    Table 111. Roche Diagnostics Prostate Cancer Screening Product
    Table 112. Roche Diagnostics Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 113. Roche Diagnostics Recent Developments
    Table 114. Rosetta Genomics Company Details
    Table 115. Rosetta Genomics Business Overview
    Table 116. Rosetta Genomics Prostate Cancer Screening Product
    Table 117. Rosetta Genomics Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 118. Rosetta Genomics Recent Developments
    Table 119. Thermo Fisher Scientific Company Details
    Table 120. Thermo Fisher Scientific Business Overview
    Table 121. Thermo Fisher Scientific Prostate Cancer Screening Product
    Table 122. Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 123. Thermo Fisher Scientific Recent Developments
    Table 124. Hologic Company Details
    Table 125. Hologic Business Overview
    Table 126. Hologic Prostate Cancer Screening Product
    Table 127. Hologic Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 128. Hologic Recent Developments
    Table 129. Myriad Genetics Company Details
    Table 130. Myriad Genetics Business Overview
    Table 131. Myriad Genetics Prostate Cancer Screening Product
    Table 132. Myriad Genetics Revenue in Prostate Cancer Screening Business (2019-2024) & (US$ Million)
    Table 133. Myriad Genetics Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Screening Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Prostate Cancer Screening Market Share by Type: 2023 VS 2030
    Figure 3. Physical Exam Features
    Figure 4. Laboratory Tests Features
    Figure 5. Imaging Tests Features
    Figure 6. Gleason Score Features
    Figure 7. TNM Score Features
    Figure 8. Genetic Tests Features
    Figure 9. Digital Rectal Exam Features
    Figure 10. Biopsy Features
    Figure 11. Global Prostate Cancer Screening Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Prostate Cancer Screening Market Share by Application: 2023 VS 2030
    Figure 13. Hospitals Case Studies
    Figure 14. Clinics Case Studies
    Figure 15. Research Labs Case Studies
    Figure 16. Cancer Institutes Case Studies
    Figure 17. Diagnostic Centers Case Studies
    Figure 18. Others Case Studies
    Figure 19. Prostate Cancer Screening Report Years Considered
    Figure 20. Global Prostate Cancer Screening Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 21. Global Prostate Cancer Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 22. Global Prostate Cancer Screening Market Share by Region: 2023 VS 2030
    Figure 23. Global Prostate Cancer Screening Market Share by Players in 2023
    Figure 24. Global Top Prostate Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Screening as of 2023)
    Figure 25. The Top 10 and 5 Players Market Share by Prostate Cancer Screening Revenue in 2023
    Figure 26. North America Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. North America Prostate Cancer Screening Market Share by Type (2019-2030)
    Figure 28. North America Prostate Cancer Screening Market Share by Application (2019-2030)
    Figure 29. North America Prostate Cancer Screening Market Share by Country (2019-2030)
    Figure 30. United States Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Canada Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Europe Prostate Cancer Screening Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. Europe Prostate Cancer Screening Market Share by Type (2019-2030)
    Figure 34. Europe Prostate Cancer Screening Market Share by Application (2019-2030)
    Figure 35. Europe Prostate Cancer Screening Market Share by Country (2019-2030)
    Figure 36. Germany Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. France Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. U.K. Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Italy Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Russia Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Nordic Countries Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Prostate Cancer Screening Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. China Prostate Cancer Screening Market Share by Type (2019-2030)
    Figure 44. China Prostate Cancer Screening Market Share by Application (2019-2030)
    Figure 45. Asia Prostate Cancer Screening Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Asia Prostate Cancer Screening Market Share by Type (2019-2030)
    Figure 47. Asia Prostate Cancer Screening Market Share by Application (2019-2030)
    Figure 48. Asia Prostate Cancer Screening Market Share by Region (2019-2030)
    Figure 49. Japan Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. South Korea Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. China Taiwan Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Southeast Asia Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. India Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Australia Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Middle East, Africa, and Latin America Prostate Cancer Screening Market Size YoY (2019-2030) & (US$ Million)
    Figure 56. Middle East, Africa, and Latin America Prostate Cancer Screening Market Share by Type (2019-2030)
    Figure 57. Middle East, Africa, and Latin America Prostate Cancer Screening Market Share by Application (2019-2030)
    Figure 58. Middle East, Africa, and Latin America Prostate Cancer Screening Market Share by Country (2019-2030)
    Figure 59. Brazil Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Mexico Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Turkey Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Saudi Arabia Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 63. Israel Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 64. GCC Countries Prostate Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 65. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 66. Almac Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 67. Bayer Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 68. Beckman Coulter Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 69. BioméRieux Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 70. Genomic Health Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 71. Mayo Clinic Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 72. Mdxhealth Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 73. Roche Diagnostics Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 74. Rosetta Genomics Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 75. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 76. Hologic Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 77. Myriad Genetics Revenue Growth Rate in Prostate Cancer Screening Business (2019-2024)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed